喘中的非编码RNAs:异氨基酸生物和呼吸道炎症的调节者
Eglė Vasylė1, Andrius Januškevičius1, Kęstutis Malakauskas1,2
1Laboratory of Pulmonology, Department of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Diagnostics (Basel, Switzerland)
|July 29, 2025
概括
非编码RNAs (ncRNAs) 是氨酸细胞发育和功能的关键调节者. 这篇评论探讨了它们在喘发病过程中的作用,并提供了对疾病机制的见解.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘是一种具有复杂,不完全理解的分子机制的慢性呼吸道炎症性疾病.
- 乙氨基是关键的免疫细胞,涉及喘病理生理学,驱动2型炎症和组织重塑.
研究的目的:
- 审查目前对异种蛋白生物学的非编码RNAs (ncRNAs) 的理解.
- 阐明ncRNAs在喘发病和进展中的作用.
主要方法:
- 关于ncRNAs,eosinophils和喘的研究的文献综述.
- 巩固关于ncrna调节异osinophil发育和功能的发现.
- 对ncRNA参与喘机制的分析.
主要成果:
- 非编码RNAs显著调节乙酸细胞的发育,分化和效应器功能.
- 特定的ncRNA已被确定为喘的关键调解者,影响炎症和呼吸道重塑.
- 对ncRNAs的失调有助于喘进展的分子基础.
结论:
- 非编码RNAs代表了氨基生物学的基因调节的关键层.
- 向ncRNAs可能为控制喘提供新的治疗策略.
- 对ncRNA-eosinophil相互作用的进一步研究对于推进喘治疗至关重要.
关键词:
呼吸道炎症 呼吸道炎症喘 喘 是一种环RNA 环RNA 是一个环RNA.埃奥西诺菲尔是什么意思在ncRNA中,我们可以这是一个小RNARNA.这是一个ncRNARNA.这就是为什么piRNARNA.更多相关视频
相关概念视频
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Antiasthma Drugs: Leukotriene Modifiers
482
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
482
Asthma: Pathogenesis and Management
597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
589
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589


